ACVRL1 and pulmonary arterial hypertension: The increased prevalence of (h)PAH in HHT1 and HHT2 could be explained by the involvement of arteriovenous malformations, caused by ALK1 and ENG mutations, in the pathophysiology in both diseases [97,98,99].